|
|
| MRD / Regn No. |
: SG2050 |
Date |
: 30/06/2026 |
| Patient Name |
: Mohammad Zakir Hossein |
Age & Gender |
: 59 Yrs. / Male |
| Contact No. |
: 8296095793 |
UHID |
: |
| Ht / Wt / BMI |
: 172 / 70 / 23.66 |
BP S / BP D |
: 117 / 75 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DIABETES (16/Nov/2021) | DYSLIPIDEMIA (16/Nov/2022) | | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
ATORVASTATIN 20 MG MODLIP 20 |
PO |
0-0-1 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
2 |
EMPAGLIFLOZIN 10 MG + LINAGLITIN 5 MG GLYXAMBI |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
3 |
GLIMEPIRIDE 2 MG + METFORMIN 500 MG + PIOGLITAZONE 15 MG AMARYL MP 2 |
PO |
1-0-1 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
4 |
LIBRAX |
PO |
0-0-1 |
BEFORE FOOD
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 02/Jul/2026 |
| Tests Suggested For Next Visit |
: HBA1C-HPLC METHOD,RETINA CHECK UP,CREATININE,LFT WITH PLATELET COUNT,UACR:SPOT SAMPLE |
| |
|
| |
|